BULLETIN # 80. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 19, 2015

Size: px
Start display at page:

Download "BULLETIN # 80. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 19, 2015"

Transcription

1 BULLETIN # 80 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on January 19, 2015 The amended Manitoba Specified Drug Regulation and Drug Interchangeability Formulary Regulation will be available on the Manitoba Health website on the effective date of January 19, 2015 Bulletin 80 is currently available for download: Inside This Issue Part 1 Additions Page 1 Part 2 Additions Page 2 Part 3 Additions Page 2-5 New Interchangeable Categories Page 5-7 New Interchangeable Products Page 7-9 Product Deletions Page 9 Category Deletions Page 10 Interchangeable Product Price Changes Page Discontinued Products Page 13

2 Part 1 Additions Bulletin #80 DIN TRADE NAME GENERIC STRENGTH FORM MFR* Abbott-Rabeprazole rabeprazole 20 mg Tablet ABB Apo-Travoprost Z travoprost 0.004% Ophthalmic APX Gabapentin gabapentin 600 mg Tablet SAH Jamp-Amlodipine Jamp-Citalopram amlodipine citalopram 5 mg 10 mg 10 mg 20 mg 40 mg Tablets Tablets Jamp-Cyanocobalamin cyanocobalamin 1 mg/ml Injection JPC Jamp-Vancomycin Mar-Amitriptyline vancomycin amitriptyline 500 mg 1 G 10 mg 25 mg 50 mg 75 mg Injection Tablets Mint-Gliclazide MR gliclazide 30 mg Tablets MPH Mint- Hydrochlorothiazide Mint- Hydroxychloroquine hydrochlorothiazide 12.5 mg 25 mg 50 mg Tablets JPC JPC JPC MAR MPH hydroxychloroquine Tablets MPH Methotrexate Injection methotrexate 25 mg/ml Injection MYL pms-latanoprost latanoprost 50 mcg/ml Sandoz Capecitabine capecitabine 150 mg 500 mg Ophthalmic Tablet Sandoz Travoprost travoprost 0.004% Ophthalmic SDZ Taro-Carbamazepine carbamazepine Tablets TAR Taro-Testosterone testosterone 40 mg s TAR PMS SDZ Teva-Travoprost Z travoprost 0.004% Ophthalmic TEV *Abbreviation of Manufacturers' Names 1 of 13

3 Part 2 Additions Bulletin # Apo-Clarithromycin XL clarithromycin 500 mg Tablet APX For treatment of patients: (a) Not responding to or intolerant of alternative antibiotics (eg. Amoxicillin and erythromycin) (b) With mycobacterial infections due to mycobacterium avium and mycobacterium intracellular; and (c) In combination therapy in the treatment of H.pylori; (d) Pneumonia; (e) Infections requiring a macrolide (including CAP in patients 65 and older) with documented intolerance to erythromycin mcg Calcitriol-Odan calcitriol ODN 0.5 mcg The management of hypocalcemia and osteodystrophy in patients with chronic renal failure undergoing dialysis and in the management of hypocalcemia in clinical manifestations associated with post surgical hypoparathyroidism, idiopathic hypoparathyroidism, pseudohypoparathyroidism, and Vitamin D resistant rickets Med-Dutasteride dutasteride 0.5 mg MED Mint-Dutasteride dutasteride 0.5 mg MPH For the treatment of symptomatic benign hyperplasia Jamp-Rizatriptan IR Teva-Rizatriptan ODT rizatriptan rizatriptan 5 mg 10 mg 5 mg 10 mg Tablet Tablet For the treatment of ACUTE migraine attacks in patients where standard therapy has failed. 250 mg VAN-Ciprofloxacin ciprofloxacin 500 mg Tablet 750 mg (a) Step-down care following hospital separation in patients treated with parenteral antibiotics; (b) Treatment of Pseudomonal infections or resistant gram-negative infections; (c) Treatment of resistant Gonococcal infections; (d) Treatment of infections in persons allergic to alternative agents (eg. penicillins, cephalosporins and sulfonamides); (e) Treatment of infections in immunocompromised patients; (f) Treatment of diabetic foot infections and complications of orthopedic surgery; (g) Treatment of chronic bacterial prostatitis. JPC TEV VAP Part 3 Additions The following products will be considered for Pharmacare reimbursement upon an individual prescriber/patient request basis Actemra (New Indication) tocilizumab 80 mg 400 mg For the treatment of active polyarticular Juvenile Idiopathic Arthritis (pjia). Injection HLR 2 of 13

4 ACT Ezetimibe ezetimibe 10 mg Tablet ACV Apo-Ezetimibe ezetimibe 10 mg Tablet APX Mar-Ezetimibe ezetimibe 10 mg Tablet MAR Mint-Ezetimibe ezetimibe 10 mg Tablet MPH pms-ezetimibe ezetimibe 10 mg Tablet PMS Ran-Ezetimibe ezetimibe 10 mg Tablet RAN Sandoz Ezetimibe ezetimibe 10 mg Tablet SDZ Teva-Ezetimibe ezetimibe 10 mg Tablet TEV For the treatment of hypercholesterolemia in patients that are intolerant or have failed to achieve cholesterol target levels on statin therapy Apo-Celecoxib celecoxib CO Celecoxib celecoxib GD-Celecoxib celecoxib Jamp-Celecoxib celecoxib Mar-Celecoxib celecoxib Mint-Celecoxib celecoxib Mylan-Celecoxib celecoxib pms-celecoxib celecoxib Ran-Celecoxib celecoxib Sandoz Celecoxib celecoxib Teva-Celecoxib celecoxib As per Celebrex criteria ( APX ACV GEM JPC MAR MPH MYL PMS RAN SDZ TEV Apo-Linezolid linezolid 600 mg Tablet APX Sandoz Linezolid linezolid 600 mg Tablet SDZ Criteria may be obtained from the EDS office at Manitoba Health Apo-Voriconazole voriconazole 50 mg Tablet Sandoz Voriconazole voriconazole 50 mg Tablet For the treatment of invasive aspergillosis or culture proven invasive candidiasis with documented resistance to fluconazole. APX SDZ 3 of 13

5 Aubagio teriflunomide 14 mg Tablet GEN For the treatment of patients 18 years or older who have relapsing-remitting MS when prescribed by a neurologist from the Manitoba MS Clinic Esbriet pirfenidone 267 mg HLR For the treatment of adult patients who have a diagnosis of mild to moderate idiopathic pulmonary fibrosis (IPF) confirmed by a respirologist Galexos simeprevir 150 mg JAN For the treatment of chronic hepatitis C genotype 1 infection in adults with compensated liver disease in combination with peginterferon alfa and ribavirin Invega Sustenna paliperidone 50 mg/0.5ml 75 mg/0.75 ml /ml 150 mg/1.5 ml Injection JAN For patients with schizophrenia: (a) With a history of non-adherence, as evidenced by outcomes such as repeated hospitalizations, or (b) Who have tried one or more antipsychotic agents, and who continue to be inadequately controlled, or are experiencing significant side effects such as EPS mg Jamp-Donepezil donepezil 10 mg As per Aricept criteria ( Tablet JPC Komboglyze saxagliptin/metformin 2.5 mg/500 mg 2.5 mg/850 mg 2.5 mg/1000 mg Tablet AZC For type 2 diabetic patients who have been titrated to a stable combination, for a minimum of at least 3 months, of the separate components, Metformin and Saxagliptin. Levemir insulin detmir 100 U/mL Injection NOO As a first line alternative, secondary to NPH (neutral protamine hagedorn) and/or premix at daily optimal dose, for patients who have been diagnosed with Type 1 or Type 2 diabetes AND who have experienced unexplained nocturnal hypoglycemia at least once a month despite optimal management OR have documented severe or continuing systemic or local allergic reaction to insulin Stivarga regorafenib 40 mg Tablet BAY For the treatment of metastatic and/or unresectable gastrointestinal stromal tumors (GIST) Tobi Podhaler tobramycin 28 mg NVT For the management of Cystic Fibrosis patients aged 6 years or older with chronic pulmonary psudomonas aeruginosa infection and who do not tolerate injectable forms of tobramycin to manage inhalation issues. 4 of 13

6 Xeomin incobotulinumtoxina 50 U Injection MPG (New Strength) Please refer to Bulletin 66 for complete criteria details Taro-Zoledronic Acid zoledronic acid 5 mg/100 ml Injection TAR Zoledronic Acid zoledronic acid 5 mg/100 ml Injection DRL As per Aclasta criteria ( New Interchangeable Categories The following new interchangeable categories and products were added: Generic Name - Strength - Form DIN Trade Name Manufacturer Price in Dollars Calcitriol mcg - s $ Rocaltrol HLR Calcitriol-Odan ODN Calcitriol mcg - s $ Rocaltrol HLR Calcitriol-Odan ODN Clarithromycin mg - Tablets $ Biaxin XL ABB Apo-Clarithromycin XL APX Celecoxib - - s $ Celebrex PFI Apo-Celecoxib APX CO Celecoxib ACV GD-Celecoxib GEM Jamp-Celecoxib JPC Mar-Celecoxib MAR Mint-Celecoxib MPH Mylan-Celecoxib MYL pms-celecoxib PMS Ran-Celecoxib RAN Sandoz Celecoxib SDZ Teva-Celecoxib TEV 5 of 13

7 Celecoxib - - s $ Celebrex PFI Apo-Celecoxib APX CO Celecoxib COB GD-Celecoxib GEM Jamp-Celecoxib JPC Mar-Celecoxib MAR Mint-Celecoxib MPH Mylan-Celecoxib MYL pms-celecoxib PMS Ran-Celecoxib RAN Sandoz Celecoxib SDZ Teva-Celecoxib TEV Ezetimibe - 10 mg - Tablets $ Ezetrol MFX ACT Ezetimibe ACV Ran-Ezetimibe RAN Sandoz Ezetimibe SDZ Teva-Ezetimibe TEV Apo-Ezetimibe APX Mar-Ezetimibe MAR Mint-Ezetimibe MPH pms-ezetimibe PMS Gliclazide - 30 mg - Tablets $ Diamicron MR SEV Gliclazide MR AAA Mint-Gliclazide MR MPH Hydrochlorothiazide mg - Tablets $ Apo-Hydro APX pms-hydrochlorothiazide PMS Mint-Hydrochlorothiazide MPH Linezolid mg - Tablets $ Zyvoxam PFI Apo-Linzolid APX Sandoz Linezolid SDZ Prazosin - 1 mg - Tablets $ Apo-Prazo APX Teva-Prazosin TEV Prazosin - 2 mg - Tablets $ Apo-Prazo APX Teva-Prazosin TEV Prazosin - 5 mg - Tablets $ Apo-Prazo APX Teva-Prazosin TEV of 13

8 Travoprost % - Opthalmic Travatan Z ALC Apo-Travoprost Z APX Sandoz Travoprost SDZ Teva-Travoprost Z TEV $ per ml Voriconazole - 50 mg - Tablets $ VFEND PFI Sandoz Voriconazole SDZ Apo-Voriconazole APX Voriconazole - - Tablets $ VFEND PFI Sandoz Voriconazole SDZ Apo-Voriconazole APX New Interchangeable Products The following products have been added to existing interchangeable drug categories: Amitriptyline - 10 mg - Tablets $ Mar-Amitriptyline MAR Amitriptyline - 25 mg - Tablets $ Mar-Amitriptyline MAR Amitriptyline - 50 mg - Tablets $ Mar-Amitriptyline MAR Amitriptyline - 75 mg - Tablets $ Mar-Amitriptyline MAR Amlodipine - 5 mg - Tablets $ Jamp-Amlodipine JPC Amlodipine - 10 mg - Tablets $ Jamp-Amlodipine JPC Capecitabine mg - Tablets $ Sandoz Capecitabine SDZ ** Capecitabine mg - Tablets $ Sandoz Capecitabine SDZ ** Carbamazepine - - Tablets $ Taro-Carbamazepine TAR Ciprofloxacin mg - Tablets $ VAN-Ciprofloxacin VAP of 13

9 Ciprofloxacin mg - Tablets $ VAN-Ciprofloxacin VAP Ciprofloxacin mg - Tablets $ VAN-Ciprofloxacin VAP Citalopram - 10 mg - Tablets $ Jamp-Citalopram JPC Citalopram - 20 mg - Tablets $ Jamp-Citalopram JPC Citalopram - 40 mg - Tablets $ Jamp-Citalopram JPC Cyanocobalamin - 1 mg/ml - Injection Jamp-Cyanocobalamin JPC $ per ml Donepezil - 5 mg - Tablets $ Jamp-Donepezil JPC Donepezil - 10 mg - Tablets $ Jamp-Donepezil JPC Dutasteride mg - s $ Med-Dutasteride MED Mint-Dutasteride MPH Gabapentin mg - Tablets $ Gabapentin SAH Hydrochlorothiazide - 25 mg - Tablets $ Mint-Hydrochlorothiazide MPH Hydrochlorothiazide - 50 mg - Tablets $ Mint-Hydrochlorothiazide MPH Hydroxychloroquine - - Tablets $ Mint-Hydroxychloroquine MPH Latanoprost - 50 mcg/ml - Ophthalmic pms-hydrochlorothiazide PMS Methotrexate - 25 mg/ml - Injection Methotrexate Injection MYL $ per ml $ per ml ** Rabeprazole - 20 mg - Tablets $ Abbott-Rabeprazole ABB of 13

10 Rizatriptan - 5 mg - Tablets $ Jamp-Rizatriptan IR JPC Rizatriptan - 10 mg - Tablets $ Jamp-Rizatriptan IR JPC Rizatriptan - 5 mg - Orally Disintegrating Tablets $ Teva-Rizatriptan ODT TEV Rizatriptan - 10 mg - Orally Disintegrating Tablets $ Teva-Rizatriptan ODT TEV Testosterone - 40 mg - s $ Taro-Testosterone TAR ** Zoledronic Acid - 5 mg/100 ml - Injection $ Taro-Zoledronic Acid TAR Zoledronic Acid DRL ** The price has resulted in a change to the lowest price in the category. The following products have been deleted. Product Deletions Apo-Nizatidine nizatidine 150 mg s Apo-Nizatidine nizatidine 300 mg s Apo-Nortriptyline nortriptyline 10 mg s Apo-Nortriptyline nortriptyline 25 mg s Dilaudid hydromorphone HCL 2 mg/ml Injection Dilaudid hydromorphone HCL 10 mg/ml Injection Norventyl nortriptyline 10 mg s pms-nortriptyline nortriptyline 10 mg s pms-nortriptyline nortriptyline 25 mg s pms-ofloxacin ofloxacin 0.3% Ophthalmic Teva-Nizatidine nizatidine 150 mg s Teva-Nizatidine nizatidine 300 mg s Teva-Nortriptyline nortriptyline 10 mg s Teva-Nortriptyline nortriptyline 25 mg s 9 of 13

11 Category Deletions Bulletin #80 - Ciprofloxacin mg - Tablets - Cyclosporine - /ml - Oral - Dihydroergotamine - 1 mg/ml - Injection - Flutamide mg - Tablets - Hydroxyzine - 10 mg - s - Hydroxyzine - 25 mg - s - Methylphenidate - 5 mg - Tablets - Sulindac - - Tablets - Triprolidine/Pseudoephedrine/Guaifenesin/Codeine - 2/30/100/10 mg per 5 ml - Expectorant - Valgancyclovir mg - Tablets Interchangeable Product Price Changes The following changes in prices have occurred: ($) Accupril quinapril 5 mg Tablets Accupril quinapril 10 mg Tablets Accupril quinapril 20 mg Tablets Accupril quinapril 40 mg Tablets Accuretic quinapril/hcl 10/12.5 mg Tablets Accuretic quinapril/hcl 20/12.5 mg Tablets Accuretic quinapril/hcl 20/25 mg Tablets Aldactazide spironolactone/hcl 25/25 mg Tablets Aldactazide spironolactone/hcl 50/50 mg Tablets Aldactone spironolactone Tablets Aldactone spironolactone 25 mg Tablets Aricept donepezil 5 mg Tablets Aricept donepezil 10 mg Tablets Aromasin exemestane 25 mg Tablets Arthrotec diclofenac/misoprostol 50 mg/200 mcg Tablets Arthrotec diclofenac/misoprostol 75 mg/200 mcg Tablets Ativan lorazepam 0.5 mg Tablets Ativan lorazepam 1 mg Tablets Ativan lorazepam 2 mg Tablets Ativan SL lorazepam 0.5 mg Tablets Ativan SL lorazepam 1 mg Tablets Ativan SL lorazepam 2 mg Tablets Cordarone amiodarone Tablets Cyklokapron tranexamic acid 500 mg Tablets of 13

12 Dalacin C clindamycin 150 mg Tablets Dalacin C clindamycin 300 mg Tablets Dalacin T clindamycin 1% Topical Duragesic MAT fentanyl 25 mcg/hr Patch Duragesic MAT fentanyl 50 mcg/hr Patch Duragesic MAT fentanyl 75 mcg/hr Patch Duragesic MAT fentanyl 100 mcg/hr Patch Effexor XR venlafaxine 75 mg s Effexor XR venlafaxine 150 mg s Effexor XR venlafaxine 37.5 mg s Lipitor atorvastatin 80 mg Tablets Neurontin gabapentin s Neurontin gabapentin 300 mg s Neurontin gabapentin 400 mg s Neurontin gabapentin 600 mg Tablets Pariet rabeprazole 10 mg Tablets Pariet rabeprazole 20 mg Tablets Provera medroxyprogesterone 5 mg Tablets Provera medroxyprogesterone 10 mg Tablets Provera medroxyprogesterone 2.5 mg Tablets Ran-Cefprozil cefprozil 25 mg/ml Suspension ** Ran-Cefprozil cefprozil 50 mg/ml Suspension ** Ran-Clarithromycin clarithromycin 500 mg Tablets ** Ran-Fentanyl fentanyl 25 mcg Patch Ran-Olanzapine olanzapine 5 mg Tablets ** Ran-Olanzapine olanzapine 15 mg Tablets ** Ran-Pravastatin pravastatin 20 mg Tablets ** Ran-Quetiapine quetiapine Tablets Ran-Valsartan valsartan 80 mg Tablets Ran-Valsartan valsartan 160 mg Tablets ratio-irbesartan HCTZ irbesartan/hctz 300/25 mg Tablets ratio-tamsulosin tamsulosin 0.4 mg s Risperdal M-Tab risperidone 0.5 mg Tablets Risperdal M-Tab risperidone 1 mg Tablets Risperdal M-Tab risperidone 2 mg Tablets Risperdal M-Tab risperidone 3 mg Tablets Risperdal M-Tab risperidone 4 mg Tablets Salazoypyrin sulfasalazine 500 mg Tablets Sandoz Ciprofloxacin ciprofloxacin 0.3% Ophthalmic Sandoz Ciprofloxacin ciprofloxacin 250 mg Tablets Sandoz Ciprofloxacin ciprofloxacin 500 mg Tablets of 13

13 Sandoz Ciprofloxacin ciprofloxacin 750 mg Tablets Sandoz Dorzolamide dorzolamide 2% Ophthalmic ** Sandoz Dutasteride dutasteride 0.5 mg s Sandoz Latano/Timolol latanoprost/timolol 0.005/0.5% Ophthalmic Sandoz polytrimethoprim 0.1% Ophthalmic Polytrimethoprim ** Sandoz Quetiapine quetiapine Ophthalmic Sandoz Risedronate risedronate 35 mg Tablets Sandoz Tamsulosin CR tamsulosin 0.4 mg Tablets Sandoz Tamsulosin SR tamsulosin 0.4 mg s Sandoz Tamsulosin SR tamsulosin 0.4 mg s Sandoz Telmisartan telmisartan 40 mg Tablets Sandoz Telmisartan telmisartan 80 mg Tablets Sandoz Timolol timolol 0.25% Ophthalmic Gel ** Sandoz Tobramycin tobramycin 0.3% Ophthalmic ** Sandoz Topiramate topiramate 25 mg Tablets Sandoz Topiramate topiramate Tablets Sandoz Topiramate topiramate Tablets Sandoz Valsartan valsartan 80 mg Tablets Sandoz Valsartan valsartan 160 mg Tablets Sandoz Valsartan valsartan 320 mg Tablets Sandoz Zolmitriptan zolmitriptan 2.5 mg Tablets Topamax topiramate 25 mg Tablets Topamax topiramate Tablets Topamax topiramate Tablets Tri-Cyclen LO ethinyl estradiol/norgestimate - Tablets Tri-Cyclen LO ethinyl estradiol/norgestimate - Tablets Xanax alprazolam 0.25 mg Tablets Xanax alprazolam 0.5 mg Tablets Xanax alprazolam 1 mg Tablets Xanax TS alprazolam 2 mg Tablets Zithromax azithromycin 250 mg Tablets Zithromax azithromycin 40 mg/ml Oral Suspension ** The price change has resulted in a change to the lowest price in the category. 12 of 13

14 Discontinued Products The following products will be deleted with the next Formulary amendments Apo-Diltiaz TZ diltiazem 120 mg s Apo-Diltiaz TZ diltiazem 180 mg s Apo-Diltiaz TZ diltiazem 240 mg s Apo-Diltiaz TZ diltiazem 300 mg s Apo-Diltiaz TZ diltiazem 360 mg s Apo-Ferrous Sulfate ferrous sulfate 300 mg Tablets Apo-Lisinopril/HCTZ lisinopril/hctz 10/12.5 mg Tablets Apo-Lisinopril/HCTZ lisinopril/hctz 20/12.5 mg Tablets Apo-Lisinopril/HCTZ lisinopril/hctz 20/25 mg Tablets Apo-Sulin sulindac 150 mg Tablets Apo-Sulin sulindac Tablets Levaquin levofloxacin 250 mg Tablets ratio-levobunolol levobunolol 0.25% Ophthalmic Teva-Anastrozole anastrozole 1 mg Tablets Teva-Fluvoxamine fluvoxamine Tablets Teva-Galanatamine ER galantamine 8 mg Tablets Teva-Galanatamine ER galantamine 16 mg Tablets Teva-Galanatamine ER galantamine 24 mg Tablets Teva-Irbesartan irbesartan 75 mg Tablets Teva-Ticlopidine ticlopidine 250 mg Tablets Teva-Verapamil SR verapamil 240 mg Tablets 13 of 13

BULLETIN # 79. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 16, 2014

BULLETIN # 79. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 16, 2014 BULLETIN # 79 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 16, 2014 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

BULLETIN # 84. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 22, 2015

BULLETIN # 84. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 22, 2015 BULLETIN # 84 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 22, 2015 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

BULLETIN # 89. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 20, 2016

BULLETIN # 89. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 20, 2016 BULLETIN # 89 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 20, 2016 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

BULLETIN # 90. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 25, 2017

BULLETIN # 90. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 25, 2017 BULLETIN # 90 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on January 25, 2017 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

BULLETIN # 74. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 17, 2013

BULLETIN # 74. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 17, 2013 BULLETIN # 74 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 17, 2013 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - November 2014 Effective November 27, 2014 Ministry of Health and Long-Term Care Table of Contents New Single Source

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - January 2015 Effective January 28, 2015 Ministry of Health and Long-Term Care Table of Contents New Multi-Source Products...

More information

BULLETIN # 78. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2014

BULLETIN # 78. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2014 BULLETIN # 78 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on July 17, 2014 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

Ontario Drug Benefit Formulary/ Comparative Drug Index

Ontario Drug Benefit Formulary/ Comparative Drug Index Ontario Drug Benefit Formulary/ Comparative Drug Index Edition 42 Summary of Changes March 2014 Effective March 27, 2014 Ministry of Health and Long-Term Care Table of Contents Additions to Formulary...

More information

BULLETIN # 98. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 19, 2018

BULLETIN # 98. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 19, 2018 BULLETIN # 98 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on April 19, 2018 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - July 2014 Effective July 30, 2014 Ministry of Health and Long-Term Care Table of Contents New Single Source Products...

More information

BULLETIN # 70. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 21, 2013

BULLETIN # 70. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 21, 2013 BULLETIN # 70 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on January 21, 2013 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - December 2014 Effective December 18, 2014 Ministry of Health and Long-Term Care Table of Contents New Multi-Source

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes August 2018 Effective August 30, 2018 Drug Programs Policy and Strategy Branch

More information

UPDATE AB Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 25, 2011 SUMMARY OF CHANGES

UPDATE AB Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 25, 2011 SUMMARY OF CHANGES UPDATE AB Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 25, 2011 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 5 Off Formulary

More information

Updates to the Alberta Drug Benefit List. Effective February 1, 2018

Updates to the Alberta Drug Benefit List. Effective February 1, 2018 Updates to the Alberta Drug Benefit List Effective February 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)

More information

Product Selection Committee / Comité de sélection des produits

Product Selection Committee / Comité de sélection des produits New Brunswick Pharmaceutical Society and New Brunswick Department of Health Product Selection Committee / Comité de sélection des produits L Ordre des pharmaciens P.O. Box / C.P. 5100, Fredericton NB E3B

More information

New Interchangeable Products Approved and Benefit Status Within the Nova Scotia Pharmacare Programs March 2016

New Interchangeable Products Approved and Benefit Status Within the Nova Scotia Pharmacare Programs March 2016 PAGE 1 OF 6 New Interchangeable Products Approved and Benefit Status Within the Nova Scotia Pharmacare Programs March New Categories A Maximum Reimbursable Price (MRP) or Pharmacare Reimbursement Price

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes April 2018 Effective April 30, 2018 Drug Programs Policy and Strategy Branch Ontario

More information

BULLETIN # 73. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2013

BULLETIN # 73. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2013 BULLETIN # 73 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on July 17, 2013 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

Updates to the Alberta Drug Benefit List. Effective May 1, 2018

Updates to the Alberta Drug Benefit List. Effective May 1, 2018 Updates to the Alberta Drug Benefit List Effective May 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780) 498-8370

More information

BULLETIN # 101. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 18, 2018

BULLETIN # 101. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 18, 2018 BULLETIN # 101 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 18, 2018 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

UPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES

UPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES UPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 3 Off

More information

Manager, PEI Drug Programs Date : December 7, 2009 Tel / Tél : (902) Fax / Téléc : (902)

Manager, PEI Drug Programs Date : December 7, 2009 Tel / Tél : (902) Fax / Téléc : (902) DRAFT To / Destinataire : All Retail Pharmacists and Staff From / Expéditeur : Faye Campbell Manager, PEI Drug Programs Date : December 7, 2009 Tel / Tél : (902) 368-6338 Fax / Téléc : (902) 368-4905 Subject

More information

UPDATE AF Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective March 26, 2012 SUMMARY OF CHANGES

UPDATE AF Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective March 26, 2012 SUMMARY OF CHANGES UPDATE AF Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective March 26, 2012 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Multi-Source Drug(s) 2 Off Formulary Interchangeable Product(s)

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes December 2018 Effective December 21, 2018 Drug Programs Policy and Strategy Branch

More information

NB Drug Plans Formulary Update

NB Drug Plans Formulary Update Bulletin #915 October 30, 2015 NB Drug Formulary Update Please find attached a list of generic drug product updates for the New Brunswick Drug Formulary. Generic drug product additions New generic products

More information

Updates to the Alberta Drug Benefit List. Effective November 1, 2018

Updates to the Alberta Drug Benefit List. Effective November 1, 2018 Updates to the Alberta Drug Benefit List Effective November 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)

More information

NBPDP Formulary Update

NBPDP Formulary Update Bulletin # 830 April 4, 2012 NBPDP Formulary Update Please find attached lists of interchangeable product additions to the New Brunswick Prescription Drug Program Formulary and non-listed products subject

More information

Updates to the Alberta Drug Benefit List. Effective August 1, 2014

Updates to the Alberta Drug Benefit List. Effective August 1, 2014 Updates to the Alberta Drug Benefit List Effective August 1, 2014 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780) 498-8370

More information

Updates to the Alberta Drug Benefit List. Effective June 1, 2018

Updates to the Alberta Drug Benefit List. Effective June 1, 2018 Updates to the Alberta Drug Benefit List Effective June 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780) 498-8370

More information

UPDATE AU Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective May 31, 2013 SUMMARY OF CHANGES

UPDATE AU Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective May 31, 2013 SUMMARY OF CHANGES UPDATE AU Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective May 31, 2013 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Multi-Source Drug(s) 2 Off Formulary Interchangeable Product(s)

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes July 2016 Effective July 28, 2016 Drug Programs Policy and Strategy Branch Ontario

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes June 2018 Effective June 29, 2018 Drug Programs Policy and Strategy Branch Ontario

More information

BULLETIN # 72. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 18, 2013

BULLETIN # 72. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 18, 2013 BULLETIN # 72 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on April 18, 2013 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

UPDATE AZ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 31, 2013 SUMMARY OF CHANGES

UPDATE AZ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 31, 2013 SUMMARY OF CHANGES UPDATE AZ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 31, 2013 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 5 Off Formulary

More information

Ontario Drug Benefit Formulary/ Comparative Drug Index

Ontario Drug Benefit Formulary/ Comparative Drug Index Ontario Drug Benefit Formulary/ Comparative Drug Index Edition 42 Summary of Changes December 2013 Effective January 03, 2014 Ministry of Health and Long-Term Care Table of Contents Additions to Formulary...

More information

BULLETIN # 65. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 14, 2010.

BULLETIN # 65. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 14, 2010. BULLETIN # 65 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 14, 2010. The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

UPDATE AJ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective July 27, 2012 SUMMARY OF CHANGES

UPDATE AJ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective July 27, 2012 SUMMARY OF CHANGES UPDATE AJ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective July 27, 2012 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 5 Off Formulary

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes September 2017 Effective September 28, 2017 Drug Programs Policy and Strategy Branch

More information

SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary

SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary Saskatchewan Ministry of Health November 1, 2010 Drug Plan and Extended Benefits Branch Bulletin #126 ISSN 1923-077X SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - February 2015 Effective February 26, 2015 Ministry of Health and Long-Term Care Table of Contents New Multi-Source

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes February 2019 Effective February 28, 2019 Drug Programs Policy and Strategy Branch

More information

NB Drug Plans Formulary Update

NB Drug Plans Formulary Update Bulletin #960 October 31, 2017 NB Drug Formulary Update Please find attached a list of generic drug product updates for the New Brunswick Drug Formulary. Generic drug product additions New generic products

More information

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs Pharmacy Benefact A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS Number 723 February 2018 Pan-Canadian Select Molecule Price Initiative for Generic Drugs Alberta Drug Benefit List prices

More information

NB Drug Plans Formulary Update

NB Drug Plans Formulary Update Bulletin #973 April 30, 2018 NB Drug Plans Formulary Update Generic drug product updates included in this bulletin: Generic drug product additions - New generic products will be reimbursed up to the category

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - October 2015 Effective October 29, 2015 Drug Program Services Branch/Ontario

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - August 2015 Effective August 26, 2015 Ministry of Health and Long-Term Care Table of Contents New Single Source Products...

More information

P R O D U C T L I S T S E P T E M B E R

P R O D U C T L I S T S E P T E M B E R PRODUCT LIST SEPTEMBER 2017 Alprazolam Tablets, USP CIV (brand-name Xanax ) 59762-3719-1 0.25 mg tablets 100 tablets/bottle 48 59762-3719-3 0.25 mg tablets 500 tablets/bottle 48 59762-3719-4 0.25 mg tablets

More information

Ontario Drug Benefit Formulary/ Comparative Drug Index

Ontario Drug Benefit Formulary/ Comparative Drug Index Ontario Drug Benefit Formulary/ Comparative Drug Index Edition 42 Summary of Changes January 2014 Effective January 30, 2014 Ministry of Health and Long-Term Care Table of Contents Additions to Formulary...

More information

SASKATCHEWAN FORMULARY BULLETIN. Update to the 60th Edition of the Saskatchewan Formulary

SASKATCHEWAN FORMULARY BULLETIN. Update to the 60th Edition of the Saskatchewan Formulary Saskatchewan Ministry of Health July 1, 2010 Drug Plan and Extended Benefits Branch Bulletin #124 ISSN 1923-077X SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes July 2017 Effective July 31, 2017 Drug Programs Policy and Strategy Branch Ontario

More information

Archived Content. This content was archived on June 24, 2013.

Archived Content. This content was archived on June 24, 2013. This content was archived on June 24, 2013. Archived Content Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after

More information

UPDATE AX Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 29, 2013 SUMMARY OF CHANGES

UPDATE AX Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 29, 2013 SUMMARY OF CHANGES UPDATE AX Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 29, 2013 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 4 Off Formulary

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes December 2017 Effective December 21, 2017 Drug Programs Policy and Strategy Branch

More information

Table 1: Price increases for Brand Name Drugs with Generic Equivalents

Table 1: Price increases for Brand Name Drugs with Generic Equivalents Table 1: Price increases for Brand Name Drugs with Generic Equivalents Brand Name Medication and Dose Total % Change Since 10/2012 ACTOS 15 MG TABLET 6.36 11.03 73.39% ACTOS 30 MG TABLET 9.7 16.80 73.23%

More information

Updates to the Alberta Health and Wellness Drug Benefit List

Updates to the Alberta Health and Wellness Drug Benefit List Updates to the Alberta Health and Wellness Drug Benefit List Effective May 1, 2012 UPDATES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST Inquiries should be directed to: Pharmacy Services Alberta

More information

UPDATE B Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 01, 2008 SUMMARY OF CHANGES

UPDATE B Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 01, 2008 SUMMARY OF CHANGES UPDATE B Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 01, 2008 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Multi-Source Drug(s) 2 Manufacturer Requested Discontinued

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes October 2017 Effective October 30, 2017 Drug Programs Policy and Strategy Branch

More information

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN TO THE 58th EDITION OF THE SASKATCHEWAN FORMULARY

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN TO THE 58th EDITION OF THE SASKATCHEWAN FORMULARY Saskatchewan Ministry of Health Drug Plan and Extended Benefits Branch July 2008 Bulletin #115 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE BULLETIN TO THE 58th EDITION OF THE SASKATCHEWAN FORMULARY

More information

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY Saskatchewan Health Drug Plan and Extended Benefits Branch April 2006 Bulletin #106 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY All

More information

Product Selection Committee / Comité de sélection des produits

Product Selection Committee / Comité de sélection des produits New Brunswick Pharmaceutical Society and New Brunswick Department of Health Product Selection Committee / Comité de sélection des produits L Ordre des pharmaciens P.O. Box / C.P. 5100, Fredericton NB E3B

More information

BULLETIN # 91. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 20, 2017

BULLETIN # 91. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 20, 2017 BULLETIN # 91 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on April 20, 2017 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes March 2019 Effective March 28, 2019 Drug Programs Policy and Strategy Branch Drugs

More information

BULLETIN # 102. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 24, 2019

BULLETIN # 102. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 24, 2019 BULLETIN # 102 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on January 24, 2019 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

NB Drug Plans Formulary Update

NB Drug Plans Formulary Update Bulletin #984 October 31, 2018 NB Drug Formulary Update Drug product updates included in this bulletin: Drug product additions - New generic products will be reimbursed up to the category Maximum Allowable

More information

Updates to the Alberta Drug Benefit List. Effective September 1, 2018

Updates to the Alberta Drug Benefit List. Effective September 1, 2018 Updates to the Alberta Drug Benefit List Effective September 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)

More information

P R O D U C T L I S T N O V E M B E R

P R O D U C T L I S T N O V E M B E R PRODUCT LIST NOVEMBER 2018 Alprazolam Tablets, USP CIV (brand-name Xanax ) 59762-3719-1 0.25 mg tablets 100 tablets/bottle 48 59762-3719-3 0.25 mg tablets 500 tablets/bottle 48 59762-3719-4 0.25 mg tablets

More information

BULLETIN # 50. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on March 13, 2006.

BULLETIN # 50. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on March 13, 2006. BULLETIN # 50 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on March 13, 2006. The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

Non-Insured Health Benefits

Non-Insured Health Benefits Spring 2015 Non-Insured Health Benefits First Nations and Inuit Health Branch Updates to the Drug Benefit List The Non-Insured Health Benefits (NIHB) Program provides supplementary health benefits, including

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes January 2018 Effective January 31, 2018 Drug Programs Policy and Strategy Branch

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes December 2016 Effective December 22, 2016 Drug Programs Policy and Strategy Branch

More information

Updates to the Alberta Drug Benefit List. Effective July 1, 2018

Updates to the Alberta Drug Benefit List. Effective July 1, 2018 Updates to the Alberta Drug Benefit List Effective July 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780) 498-8370

More information

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN FOR THE UPDATE TO THE 56th EDITION OF THE SASKATCHEWAN FORMULARY

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN FOR THE UPDATE TO THE 56th EDITION OF THE SASKATCHEWAN FORMULARY Saskatchewan Health Drug Plan and Extended Benefits Branch January 2007 Bulletin #109 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE BULLETIN FOR THE UPDATE TO THE 56th EDITION OF THE SASKATCHEWAN FORMULARY

More information

PEI Drug Programs. Issue October, 2006

PEI Drug Programs. Issue October, 2006 PEI Drug Programs Formulary Update Issue 06-04 October, 2006 The following changes and additions to the July 2006 edition of the PEI Drug Programs Formulary will be effective th October 16, 2006 unless

More information

BULLETIN # 99. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 19, 2018

BULLETIN # 99. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 19, 2018 BULLETIN # 99 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on July 19, 2018 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes June 2017 Effective June 29, 2017 Drug Programs Policy and Strategy Branch Ontario

More information

UPDATE F Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective 30 January, 2009 SUMMARY OF CHANGES

UPDATE F Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective 30 January, 2009 SUMMARY OF CHANGES UPDATE F Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective 30 January, 2009 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 3 Manufacturer

More information

Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, 2018 New Categories

Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, 2018 New Categories PAGE 1 OF 7 Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, New Categories A Maximum Reimbursable Price (MRP) or Pharmacare Reimbursement Price (PRP) has been established for

More information

Amitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil

Amitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil School Corp Formulary Antiviral Acyclovir 400mg Zovirax Asthma Advair Diskus Diskus 250/50 Fluticasone/Salmeterol Asthma Albuterol Sulfate 2.5 mg/3 ml Proventil Arthritis and Pain Allendronate Sodium 70

More information

Archived Content. This content was archived on June 24, 2013.

Archived Content. This content was archived on June 24, 2013. This content was archived on June 24, 2013. Archived Content Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after

More information

BULLETIN # 66. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on November 24, 2011.

BULLETIN # 66. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on November 24, 2011. BULLETIN # 66 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on November 24, 2011. The amended Manitoba Specified Drug Regulation and Drug

More information

Non-Insured Health Benefits

Non-Insured Health Benefits Winter 2017 Non-Insured Health Benefits First Nations and Inuit Health Branch Updates to the Drug Benefit List The Non-Insured Health Benefits (NIHB) Program provides supplementary health benefits, including

More information

Professionalism & Service with Great Prices

Professionalism & Service with Great Prices Acyclovir Capsules 200mg Viruses 30 90 Albuterol Syrup 2mg/5ml Asthma 120 360 Albuterol Sulfate Solution 0.05% * Asthma ----- ----- 20 60 Albuterol Sulfate Solution 0.083% Asthma ----- ----- 75 225 Alendronate

More information

Amitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil

Amitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil Antiviral Acyclovir 400mg Zovirax Asthma Advair Diskus Diskus 250/50 Fluticasone/Salmeterol Asthma Albuterol Sulfate 2.5 mg/3 ml Proventil Arthritis and Pain Allendronate Sodium 70 mg Fosamax Arthritis

More information

TennCare Program TN MAC Price Change List As of: 03/30/2017

TennCare Program TN MAC Price Change List As of: 03/30/2017 1 TN List Run : 03/30/17 Old PRAZOSIN HCL 5 MG CAPSULE ORAL 03/29/2017 1.11209 1.12560 ( 1.2) CAPTOPRIL 12.5 MG TABLET ORAL 07/07/2015 1.07191 1.10416 ( 2.9) ISOSORBIDE DINITRATE 5 MG TABLET ORAL 03/29/2017

More information

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018 ANTIDEPRESSANTS EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 120 MG ORAL FETZIMA

More information

Pharmacy Consultant, PEI Drug Programs Date : September 8, 2009 Tel / Tél : (902) Fax / Téléc : (902)

Pharmacy Consultant, PEI Drug Programs Date : September 8, 2009 Tel / Tél : (902) Fax / Téléc : (902) To / Destinataire : All Retail Pharmacists and Staff From / Expéditeur : Patrick Crawford Pharmacy Consultant, PEI Drug Programs Date : September 8, 2009 Tel / Tél : (902) 368-6711 Fax / Téléc : (902)

More information

Summary of Changes to the Alberta Health and Wellness Drug Benefit List

Summary of Changes to the Alberta Health and Wellness Drug Benefit List Summary of Changes to the Alberta Health and Wellness Drug Benefit List Effective April 1, 2010 ABC 40211/81160 (R2010/04) Table of Contents Special Authorization...1 New Drug Product(s) Available by Special

More information

UPDATE Z Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 04, 2011 SUMMARY OF CHANGES

UPDATE Z Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 04, 2011 SUMMARY OF CHANGES UPDATE Z Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 04, 2011 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 4 Off Formulary

More information

NB Drug Plans Formulary Update

NB Drug Plans Formulary Update Bulletin # 995 March 27, 2019 NB Drug Plans Formulary Update This update to the New Brunswick Drug Plans Formulary is effective March 27, 2019. Included in this bulletin: Special Authorization Benefit

More information

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M % June 2016 On 13th May, the DH announced that there would be reductions to Category M prices from June until September. http://psnc.org.uk/our-news/contractor-notice-category-m-price-reduction/ This has

More information

New Exception Status Benefits

New Exception Status Benefits JULY 2012 Nova Scotia Formulary Updates New Exception Status Benefits Criteria Update: Xarelto Criteria Update: Sutent New Diabetic Products PRP Non-Insured Products Pharmacare Reimbursement Changes to

More information

Non-Insured Health Benefits

Non-Insured Health Benefits Fall 2016 Non-Insured Health Benefits First Nations and Inuit Health Branch Updates to the Drug Benefit List The Non-Insured Health Benefits (NIHB) Program provides supplementary health benefits, including

More information

NBPDP Formulary Update

NBPDP Formulary Update Bulletin # 880 January 28, 2014 NBPDP Formulary Update Please find attached a list of interchangeable product additions to the New Brunswick Prescription Drug Program Formulary. Existing interchangeable

More information

UPDATE AE Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective February 29, 2012 SUMMARY OF CHANGES

UPDATE AE Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective February 29, 2012 SUMMARY OF CHANGES UPDATE AE Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective February 29, 2012 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 6 Off Formulary

More information

Non-Insured Health Benefits

Non-Insured Health Benefits Winter/Spring 2014 Non-Insured Health Benefits First Nations and Inuit Health Branch Updates to the Drug Benefit List The Non-Insured Health Benefits (NIHB) Program provides supplementary health benefits,

More information

TN Cover Rx Tennessee CoverRx MAC Price Change List As of: 04/26/2018

TN Cover Rx Tennessee CoverRx MAC Price Change List As of: 04/26/2018 1 Tennessee CoverRx List Run : 04/26/18 Dosage Form amiodarone HCl 200 MG TABLET ORAL 04/25/2018 0.16102 0.14405 11.8 hydralazine HCl 100 MG TABLET ORAL 04/25/2015 0.11390 0.10854 4.9 hydralazine HCl 25

More information

Updates to the Alberta Drug Benefit List. Effective October 1, 2017

Updates to the Alberta Drug Benefit List. Effective October 1, 2017 Updates to the Alberta Drug Benefit List Effective October 1, 2017 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)

More information

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 57th EDITION OF THE SASKATCHEWAN FORMULARY

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 57th EDITION OF THE SASKATCHEWAN FORMULARY Saskatchewan Health Drug Plan and Extended Benefits Branch April 2008 Bulletin #114 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 57th EDITION OF THE SASKATCHEWAN FORMULARY The

More information